Tobradex ST contains tobramycin, an antibacterial drug, and dexamethasone, a potent corticosteroid. Eyevance announced the launch of Tobradex® ST (tobramycin ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Applications (NDAs) ...

Please provide your email address to receive an email when new articles are posted on . Eye care pharmaceutical company Harrow announced the completed transfer of new drug applications for Flarex, ...

FORT WORTH, Texas, March 2, 2020 /PRNewswire/ -- Eyevance Pharmaceuticals, committed to developing and commercializing innovative and impactful ophthalmic products ...

ALLEGAN, Mich., March 21, 2022 /PRNewswire/ -- Padagis today announced the FDA approval and launch of an AB-rated generic version of Tobradex® Ophthalmic Suspension. Tobradex® Ophthalmic Suspension is ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved an abbreviated new drug application for Alembic Pharmaceuticals’ tobramycin ophthalmic ...